Navigation Links
Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
Date:4/4/2008

e separation of stem cell populations for BTI's cell therapy work."

About Bioprocessing Technology Institute (BTI)

Bioprocessing Technology Institute (BTI) is a member of the Agency for Science, Technology and Research (A*STAR). Established in 1990 as the Bioprocessing Technology Unit, it was renamed the Bioprocessing Technology Institute (BTI) in 2003. The research institute's mission is to develop manpower capabilities and establish cutting-edge technologies relevant to the bioprocessing community. Some of the key research areas include expression engineering, animal cell technology, stem cell research, microbial fermentation, downstream purification and analytics. More information on BTI can be found at http://www.bti.a-star.edu.sg.

About Raven biotechnologies

Raven biotechnologies, inc. (http://www.ravenbio.com) is a privately held biotechnology company focused on the development of monoclonal antibody therapeutics for treating cancer. Raven's lead product candidate, RAV12, targets adenocarcinomas and is in clinical development for the treatment of gastrointestinal and other cancers. Raven's discovery process simultaneously identifies cell-surface drug targets and the antibody therapeutics to regulate them. Our focus on biological function allows us to rapidly identify novel target antigens and therapeutic candidates in their native configuration in the intact cell membrane. Our integrated approach is based on proprietary methods for optimizing the production of MAbs targeting cell-surface proteins, including the use of human tissue-specific progenitor and tumor stem cell lines developed at Raven.

To date Raven has identified multiple candidate therapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast and ovarian cancer.


'/>"/>
SOURCE Raven biotechnologies, inc.; Bioprocessing TechnologyInstitute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VaxGen and Raven Terminate Merger Agreement
2. Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections
3. Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO
4. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
5. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
6. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
7. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
8. First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP
9. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
10. Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim
11. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Guggenheim Securities, the ... today announced the hiring of veteran equity analyst Charles ... analyst. Mr. Butler will focus on the biotech/biopharma sector. ... a wealth of experience and a broad network of ... Senior Managing Director and Head of Equities at Guggenheim ...
(Date:8/27/2014)... Aug. 27, 2014  ARCH Venture Partners, one ... in the development of seed and early-stage advanced ... fund closed with more than $400 million in ... million subscription target by more than $150 million. ... the strength and potential of our approach to ...
(Date:8/27/2014)... According to the 2013 Raw Material ... look and feel of markets for raw materials and ... will push for more branded, science-backed products.” , Natural ... market growth in the last decade as consumers increasingly ... cosmetics to fit a more ‘wellness’ lifestyle approach. ...
(Date:8/26/2014)... , Aug. 26, 2014  NeuroSigma, Inc., a ... to develop bioelectronic technologies, today announced that it has ... U.S. Securities and Exchange Commission relating to a proposed ... of shares to be offered and the price range ... Jefferies LLC will act as the book-running ...
Breaking Biology Technology:Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3
... that helps solve the structure of graphite oxide and ... thick substance called graphene, which has applications in nanoelectronics, ... and cars has been created by researchers at The ... idea of the nanomaterial graphene, imagine a lightweight material ...
... Sept. 25 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc.,("Dragon Pharma" ... DRP), a,leading international pharmaceutical company, today announced that ... Wong, Chief Financial,Officer will present at 9:30 a.m. ... 2008 at the Chateau Frontenac hotel in Quebec ...
... Expects Revenue of $88 to $90 Million and Net Income of $27 ... ... China, Sept. 25 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky One ... company producing over-the-counter,drugs in the People,s Republic of China ("PRC"), today announced ...
Cached Biology Technology:New graphene-based material clarifies graphite oxide chemistry 2New graphene-based material clarifies graphite oxide chemistry 3China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 2China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 3
(Date:8/27/2014)... Wis. The mechanical force that a single fungal cell ... vanishingly small, but it plays a heavy role in setting ... In fact, it may not be too much of a ... land without the ability to respond to the touch of ... An, a professor of agronomy at the University of Wisconsin-Madison. ...
(Date:8/27/2014)... FREMONT, Calif. , Aug. 27, 2014  WaferGen ... completed its previously announced underwritten public offering of units ... $10,000 per unit for gross proceeds of $20 million, ... expenses payable by the Company.  The shares and warrants ... Each unit sold in the offering consists ...
(Date:8/27/2014)... mastodons, short-faced bears, giant ground sloths, saber-toothed cats ... 13,000 years ago at the end of the Pleistocene ... been debated by scientists who, until recently, could only ... including UC Santa Barbara,s James Kennett, professor emeritus in ... collision with Earth played a major role in the ...
Breaking Biology News(10 mins):A touching story: The ancient conversation between plants, fungi and bacteria 2A touching story: The ancient conversation between plants, fungi and bacteria 3WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3Nanodiamonds are forever 2Nanodiamonds are forever 3
... -- The genes that make a fruit fly,s eyes red ... in South and Central America, finds a new study by ... ecology and evolutionary biology, discovered that genes involved in making ... pigments in butterflies. This finding sheds light on the genetic ...
... dictate the array of fall colors as much as the ... of North Carolina. By taking careful stock and ... maple trees along transects from floodplains to ridge-tops in a ... at Charlotte graduate student Emily M. Habinck found that in ...
... brightly coloured tropical frog under threat of extinction is the ... how environment and diet influence its development and behaviour. ... experts at Chester Zoo in the hope that their findings ... calcarifer from extinction in the wild but provide clues as ...
Cached Biology News:Why do autumn leaves bother to turn red? 2Frog study takes leaf out of nature's book 2
... Sigmas FLAG Immunoprecipitation kit allows a ... of an active FLAG-tagged protein. The ... gel, which is a highly specific ... resin. The use of affinity resin ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: rack ...
... is a chromogenic medium for the ... Salmonella (except S. thyphi) and total ... detection takes a maximum of 24 ... no sterilization during preparation and performs ...
This modular benchtop laminar flow hood forces air through a 99.99% efficient HEPA filter to create a clean processing area. Options include a work bench, ionizaing bar, and air velocity gauge....
Biology Products: